What’s Best for DCIS?

Recent breast cancer mortality data have prompted suggestions that a more conservative approach to treating ductal carcinoma in situ may be appropriate in many cases. Cleveland Clinic Cancer Center radiation oncologist Chirag Shah, MD, and colleagues provide perspective on what’s known and what additional research is needed.